HeartSciences Inc. (HSCS) Change in Account Payables (2021 - 2026)

HeartSciences (HSCS) has reported Change in Account Payables for 6 consecutive years, with -$92400.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Account Payables fell 6.93% year-over-year to -$92400.0; the trailing twelve-month figure through Apr 2026 stood at -$180086.0 (down 39.04% YoY), and the FY2026 full-year result was -$334.0, up 99.74% from the prior year.
• Change in Account Payables declined to -$92400.0 in Q2 2026 per HSCS's latest filing, from $34165.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $633457.0 in Q4 2023 and bottomed at -$673221.0 in Q1 2024.
• Historically, Change in Account Payables has averaged -$5888.4 across 5 years, with a median of -$35436.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 970.47% in 2023, then slumped 374.31% in 2024.
• Over 5 years, Change in Account Payables stood at $339522.0 in 2022, then soared by 86.57% to $633457.0 in 2023, then sank by 118.89% to -$119658.0 in 2024, then soared by 128.55% to $34165.0 in 2025, then tumbled by 370.45% to -$92400.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$92400.0, $34165.0, and -$35436.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.